Country Club Trust’s VanEck Pharmaceutical ETF PPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-15,675
Closed -$890K 259
2018
Q1
$890K Buy
+15,675
New +$937K 0.11% 131
2017
Q2
Sell
-12,489
Closed -$688K 210
2017
Q1
$688K Buy
+12,489
New +$677K 0.09% 126
2016
Q2
Sell
-5,735
Closed -$330K 211
2016
Q1
$330K Buy
5,735
+285
+5% +$16.9K 0.05% 171
2015
Q4
$356K Buy
5,450
+40
+0.7% +$2.58K 0.05% 183
2015
Q3
$341K Buy
5,410
+1,215
+29% +$85.4K 0.05% 182
2015
Q2
$297K Buy
4,195
+175
+4% +$12.6K 0.04% 197
2015
Q1
$282K Hold
4,020
0.04% 188
2014
Q4
$258K Buy
+4,020
New +$256K 0.03% 202
2014
Q1
Sell
-3,783
Closed -$201K 219
2013
Q4
$201K Buy
+3,783
New +$192K 0.03% 211

Other funds holding PPH

Country Club Trust's PPH Position: Q2 2018 in Review

Country Club Trust sold out of VanEck Pharmaceutical ETF (PPH) in Q2 2018, closing a stake of 15,675 shares — an estimated $890K sold.

Country Club Trust first reported a position in PPH in Q4 2013 and held it in 9 quarters. The position peaked at $890K in Q1 2018. 49 funds tracked by Wall St. Rank hold PPH as of Q2 2018.

  • Country Club Trust reported no remaining VanEck Pharmaceutical ETF position as of Q2 2018 after selling out during the quarter.
  • Country Club Trust sold 15,675 VanEck Pharmaceutical ETF shares in Q2 2018, an estimated $890K.
  • Country Club Trust first reported a position in VanEck Pharmaceutical ETF in Q4 2013 and held it in 9 quarters.
  • Country Club Trust's VanEck Pharmaceutical ETF position peaked at $890K in Q1 2018.
  • 49 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2018.

Based on Country Club Trust's 13F filing for Q2 2018, filed 3 Aug 2018.